NEW YORK, September 27, 2017 /PRNewswire/ --
If you want a Stock Review on CHFS, RWLK, LNTH, or ARAY then come overto http://dailystocktracker.com/register/ and sign up for your free customized report. Pre-market today, DailyStockTracker.com presents for scanning CHF Solutions Inc. (NASDAQ: CHFS), ReWalk Robotics Ltd (NASDAQ: RWLK), Lantheus Holdings Inc. (NASDAQ:
On Tuesday, shares in Eden Prairie, Minnesota-based CHF Solutions Inc. recorded a trading volume of 275,479 shares. The stock ended the session 0.17% lower at $0.58. The Company's shares are trading 14.30% below their 50-day moving average. Moreover, shares of CHF Solutions, which develops cardiac and coronary disease products primarily in the US, have a Relative Strength Index (RSI) of 38.58.
On August 29th, 2017, CHF Solutions announced that it has added six seasoned sales professionals to its commercial sales organization to better serve its customer demand. The new sales representatives joined the Company from top-tiered medical device organizations and bring deep levels of expertise and market development success. The newly hired sales professionals will focus on enhancing existing account penetration and on new business development. The free research report on CHFS is available at:
Yokneam Ilit, Israel headquartered ReWalk Robotics Ltd's stock closed the day 1.72% higher at $1.48 with a total trading volume of 226,960 shares. The Company's shares are trading 1.94% below their 50-day moving average. Shares of the Company, which designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions, are an RSI of 43.09.
On September 14th, 2017, ReWalk Robotics announced that one of the leading German insurers, Barmer, has signed a confirmation regarding the provision of ReWalk systems for all qualifying beneficiaries. This confirms the procurement of exoskeletons for users that meet the inclusion criteria and reach successful assessment by the German Medical Service of the Health Insurers before and after training. The complimentary report on RWLK can be downloaded at:
Shares in North Billerica, Massachusetts headquartered Lantheus Holdings Inc. recorded a trading volume of 483,742 shares. The stock ended yesterday's trading session 0.29% lower at $17.45. The Company's shares have advanced 2.05% in the past month, 8.05% in the previous three months, and 102.91% on an YTD basis. The stock is trading above its 200-day moving average by 26.38%. Furthermore, shares of Lantheus, which develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide, have an RSI of 50.18. Visit us today and download our complete research report on LNTH for free at:
Sunnyvale, California headquartered Accuray Inc.'s stock finished Tuesday's session 1.12% lower at $4.40. A total volume of 689,004 shares was traded, which was above their three months average volume of 467,600 shares. The Company's shares have advanced 7.32% in the last one month. The stock is trading above its 50-day moving average by 3.64%. Additionally, shares of Accuray, which designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body, have an RSI of 55.83.
On September 20th, 2017, Accuray announced that data and first-hand experience with its advanced CyberKnife® and Radixact™ Systems, and unique software solutions, will be shared by leading radiation oncology practitioners at the 2017 ASTRO (American Society for Radiation Oncology) Annual Meeting from September 24th, 2017 to September 27th, 2017 in San Diego, California. Meeting attendees are invited to visit Accuray booth #1517 throughout the meeting to see software demonstrations, hear from industry experts, and speak with Company representatives. Get free access to your technical report on ARAY at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All